Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case report
Open Access
- 1 January 2008
- journal article
- case report
- Published by Medical Journals Sweden AB in Acta Orthopaedica
- Vol. 79 (4), 565-567
- https://doi.org/10.1080/17453670710015580
Abstract
(2008). Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case report. Acta Orthopaedica: Vol. 79, No. 4, pp. 565-567.Keywords
This publication has 8 references indexed in Scilit:
- An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?Injury, 2008
- Long-Term Safety of BisphosphonatesJournal of Clinical Endocrinology & Metabolism, 2005
- Severely Suppressed Bone Turnover: A Potential Complication of Alendronate TherapyJournal of Clinical Endocrinology & Metabolism, 2005
- THe effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog ribJournal of Bone and Mineral Metabolism, 2005
- Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beaglesBone, 2001
- Bisphosphonates: Mechanisms of ActionEndocrine Reviews, 1998
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesThe Lancet, 1996
- Effects of differences in mineralization on the mechanical properties of bonePhilosophical Transactions of the Royal Society of London. B, Biological Sciences, 1984